Drugs / Cytokine Induced Killer (CIK) cells
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1/2 | NCT01894373 | Jun 2015 → Jun 2017 | psoriasis | Chinese PLA General Hospital | Completed | No outcome recorded |
Evidence & citations 4 cited values
Every value below carries the sentence it was read from. 2 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | cytokine-induced killer (CIK) cells | “Biological: in vitro expanded Cytokine Induced Killer (CIK) cells Procedure: Infusion of autologous CIK cells” NCT01894373 ↗ |
| Known as | CIK | ClinicalTrials.gov intervention name — accepted as the source's own label NCT01894373 ↗ |
| Modality | Cell therapy | “Autologous cytokine-induced killer (CIK) cell infusion” PMID 30100374 ↗ Aug 2018 |
| Route | Other | “Procedure: Infusion of autologous CIK cells” NCT01894373 ↗ |